Robert Stanislaro is a Senior Managing Director in the Strategic Communications segment at FTI Consulting. He is based in New York.
Mr. Stanislaro uses his extensive healthcare and life sciences experience to counsel clients around the world on matters that affect what is most important: enterprise value.
Throughout his career, Mr. Stanislaro has developed communications programs for leading healthcare and life sciences companies and medical societies, including Takeda, bluebird bio, Shire, Eli Lilly, Astellas, GE Healthcare, Smith & Nephew and the American Society of Anesthesiologists. These programs have focused on positioning his clients as thought leaders in their respective industries, communicating through strategic transition periods and supporting a number of inflection points, including clinical trial results, product approvals and divestitures, financings, collaborations, mergers and acquisitions, peer-reviewed research and management changes.
Mr. Stanislaro also has considerable experience working with emerging biotechnology companies and research organizations, including ImmunoGen, TESARO, Karyopharm, Kiniksa, Quintiles and Duke Clinical Research Institute.
Mr. Stanislaro holds an M.B.A. in marketing from Baruch College’s Zicklin School of Business and a B.S. in biology from Wagner College.